Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetirizine for Opioid-Induced Pruritus
NCT01825655Phase 4Terminated
- Sponsor
- Virginia Commonwealth University
- Start
- Sep 2014
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in opioid-induced pruritus (OIP) comparing Cetirizine with Placebo (2 arms). Primary endpoint: Change in Itch Score at 3 hours. Started Sep 2014; status: terminated.
02
Drugs
cetirizine
03
Conditions
opioid-induced pruritus (OIP)
Beyond the preview
Go deeper on NCT01825655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01825655.